Business Context and Reporting Period
This Form 8-K Current Report was filed by Novavax, Inc. on November 27, 2009. The filing addresses a corporate governance change regarding the appointment of certain officers.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The Board of Directors determined that the roles of principal financial officer and principal accounting officer should be consolidated into a single position. Consequently:
- Evdoxia E. Kopsidas was relieved of her duties as principal accounting officer.
- Frederick W. Driscoll, the Company's Vice President, Chief Financial Officer, and Treasurer, was appointed as the principal accounting officer, effective immediately.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risks, contingencies, or unusual items. The document is limited to the disclosure of the officer appointment under Item 5.02.
Investor Verification Checklist
- Confirm the effective date of the principal accounting officer change (November 27, 2009).
- Verify the new reporting structure where the CFO also serves as the principal accounting officer.
- Review subsequent filings for any financial data or operational updates not included in this 8-K.